On this page you will find all of ACB’s publications. To the right are the search categories that will help you navigate around the ACB’s extensive work.
We, the undersigned civil society organisations in Africa, hereby call upon the Bill and Melinda Gates Foundation and the Target Malaria project to stop the intended release of 10 000 genetically modified (GM) “male sterile” mosquitoes in Burkina Faso, as the release poses unacceptable risks to human beings and the environment.
A decade ago, genetically modified (GM) mosquitoes were first released globally, in the Cayman Islands, by UK-based company Oxitec. Further releases followed in Malaysia, Panama and Brazil.
This ACB report explores issues relating to farmers’ independent seed development, production and distribution. Drawing from innovative case studies in Brazil, East Africa and elsewhere, suggestions are presented to strengthen farmer quality control practices.
Press Release from the African Centre for Biodiversity
AU’s premature and misguided endorsement of controversial, unproven gene drive mosquitos for malaria ‘eradication’ in Africa
Johannesburg, Monday, 5 November 2018
At the National Seed Dialogue and Celebration, hosted by the African Centre for Biodiversity at Constitution Hill in December 2017, this session on Participatory Plant Breeding and Smallholder Farmers looked at issues of smallholder farmers & seed breeding/crop improvement and the pot
Genetically modified (GM) “male-sterile” mosquitoes are due to be released in Burkina Faso this year by the Target Malaria research consortium. However, Target Malaria acknowledges that there are no benefits to the proposed GM mosquito release.
In this briefing paper ACB, TWN and GeneWatch UK discuss that genetically modified (GM) mosquitoes were exported from Imperial College in London to Burkina Faso in November 2016. They are currently in “contained use” facilities in Bobo-Dioulasso, and are being used in experiments by a research consortium called Target Malaria.
The Water Efficient Maize for Africa (WEMA) project promises to develop drought tolerance in maize for the benefit of small holder farmers, but is really a project designed to facilitate the spread of hybrid and genetically modified (GM) maize varieties on the continent.
In this Alert, the ACB warns that the South African government received an application for the commodity clearance (import for food, feed and processing) of a ‘multi-stacked variety’ of genetically modified (GM) maize – MON87427 × MON89034 × MIR162 × MON87411, which represents the entry of the second generation of genetically modified organisms
Seed policy in sub-Saharan Africa is developing and changing fast, as the seed industry continues to expand its reach. A huge amount of energy and resources are being directed at harmonising seed and intellectual property legislation at the regional level through regional economic communities.
A new report from the ACB, “The GM maize onslaught in Mozambique: Undermining biosafety and smallholder farmers” written in conjunction with Acção Academicapara o Desenvolvimento das Comunidades Rurais (ADECRU) has been released today.
In this objection, ACB raises numerous concerns with the application by Monsanto for the commercial release of the triple stacked event.
In December 2016 Monsanto shareholders voted in favour of the sale of the company to Bayer for US$66 billion, making it the largest-ever foreign corporate takeover by a German company. Both Bayer and Monsanto are major global manufacturers of agrochemicals and seeds, including genetically modified seed.
This lobby paper Who will feed Africans: Small-scale farmers not corporations! produced by the partnership between FoEA and ACB, makes the compelling case for African agriculture to transition towards agroecology and food sovereignty, recognising and strengthening the role of small scale farmers, rather than benefiting few large scale c